Christopher A. Viehbacher is the former CEO of Sanofi. During his six year tenure, Sanofi completed over $30 billion of acquisitions, including Genzyme. Prior to Sanofi, Viehbacher spent 20 years with GlaxoSmithKline, ultimately as President of GSK's North American pharmaceutical division.
He was a Member of the Board of Directors of GSK plc and Co-President of GSK's Portfolio Management Board. Viehbacher began his career with Price Waterhouse Coopers and qualified as a Chartered Accountant.
Viehbacher has been Chairman of the Board of the Pharmaceutical Research and Manufacturers of America (PhRMA), as well as President of the European Federation of Pharmaceutical Industries and Associations. He has received France's highest civilian honour, the Legion d'Honneur.